Literature DB >> 23709544

Chryseobacterium indologenes peritonitis in peritoneal dialysis.

Mehdi Afshar1, Ehsan Nobakht, Susie Q Lew.   

Abstract

Peritoneal dialysis-related peritonitis remains a major complication of peritoneal dialysis in patients with end-stage renal disease. Chryseobacterium indologenes is a rare organism that has been reported to cause infections mostly in hospitalised patients with severe underlying diseases. We report the first case of C indologenes peritonitis in a patient on peritoneal dialysis outside of Asia. Our patient with end-stage renal disease on peritoneal dialysis grew C indologenes from peritoneal fluid when he presented with abdominal pain and cloudy effluent. The patient responded well to intraperitoneal antibiotic therapy. Tenckhoff catheter did not require removal. This case demonstrates the importance of considering rare causes of peritonitis, such as C indologenes, in patients on peritoneal dialysis. Given the resistance of such organisms to commonly used broad-spectrum antibiotics, antimicrobial susceptibility testing must be assessed as early as possible to assure appropriate antibiotic coverage to avoid untreated peritonitis leading to peritoneal dialysis failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23709544      PMCID: PMC3669985          DOI: 10.1136/bcr-2013-009410

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device.

Authors:  E Nulens; B Bussels; A Bols; B Gordts; H W Van Landuyt
Journal:  Clin Microbiol Infect       Date:  2001-07       Impact factor: 8.067

2.  Cellulitis and bacteraemia due to Chryseobacterium indologenes.

Authors:  B T Green; P E Nolan
Journal:  J Infect       Date:  2001-04       Impact factor: 6.072

3.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

4.  Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient.

Authors:  S Shah; U Sarwar; E A King; A Lat
Journal:  Transpl Infect Dis       Date:  2012-01-29       Impact factor: 2.228

5.  Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.

Authors:  Fu-Lun Chen; Giueng-Chueng Wang; Sing-On Teng; Tsong-Yih Ou; Fang-Lan Yu; Wen-Sen Lee
Journal:  J Microbiol Immunol Infect       Date:  2012-09-27       Impact factor: 4.399

6.  Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients. Microbiological observations.

Authors:  M J Bonten; F H van Tiel; S van der Geest; H G Smeets; E E Stobberingh; C A Gaillard
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

7.  Chryseobacterium in burn wounds.

Authors:  N Kienzle; M Muller; S Pegg
Journal:  Burns       Date:  2001-03       Impact factor: 2.744

8.  Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia.

Authors:  Yi-Tsung Lin; Yuan-Yu Jeng; Mei-Lin Lin; Kwok-Woon Yu; Fu-Der Wang; Cheng-Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2010-12       Impact factor: 4.399

9.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Profile and multidrug resistance determinants of Chryseobacterium indologenes from seawater and marine fauna.

Authors:  Ana Maravić; Mirjana Skočibušić; Ivica Samanić; Jasna Puizina
Journal:  World J Microbiol Biotechnol       Date:  2012-11-07       Impact factor: 3.312

View more
  5 in total

Review 1.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Chryseobacterium indologenes pneumonia in a patient with non-Hodgkin's lymphoma.

Authors:  Hameed Aboobackar Shahul; Mohan K Manu; Aswini Kumar Mohapatra; Kiran Chawla
Journal:  BMJ Case Rep       Date:  2014-09-23

3.  A Case of Healthcare Associated Pneumonia Caused by Chryseobacterium indologenes in an Immunocompetent Patient.

Authors:  Salih Atakan Nemli; Tuna Demirdal; Serap Ural
Journal:  Case Rep Infect Dis       Date:  2015-01-06

4.  Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation.

Authors:  Osamu Imataki; Makiko Uemura
Journal:  Clin Case Rep       Date:  2016-12-15

5.  Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report.

Authors:  Mahdi M Fadlallah; Darine M Kharroubi; Zeinab Zeineddine; Sarah M Salman
Journal:  Cureus       Date:  2022-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.